title: Eight years after Jesse 's death, are human research subjects any safer?
authors.forename: Paul
authors.initials: P
authors.lastname: Gelsinger
authors.forename: Adil E
authors.initials: AE
authors.lastname: Shamoo
mesh_terms: D000256:Adenoviridae / Q000276:immunology; D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems / Q000331:legislation & jurisprudence*; D002986:Clinical Trials as Topic / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence*; D017321:Clinical Trials, Phase I as Topic / Q000331:legislation & jurisprudence; D016265:Conflict of Interest; D004345:Drug Industry / Q000191:economics / Q000941:ethics; D017809:Fatal Outcome; D036281:Genetic Research / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence*; D015316:Genetic Therapy / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence*; D005822:Genetic Vectors / Q000276:immunology; D006801:Humans; D033181:Information Dissemination; D008297:Male; D009102:Multiple Organ Failure; D009954:Ornithine Carbamoyltransferase / Q000235:genetics; D020163:Ornithine Carbamoyltransferase Deficiency Disease; D010414:Pennsylvania; D035842:Research Subjects; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D009954:Ornithine Carbamoyltransferase